MNOV

Medicinova, Inc.
Data: 2026-01-30
$1.72
Price
-0.86%
Change
$2.06
52W High
$1.13
52W Low

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Quick Stats
Jan 30, 2026

58.5

AI Score

HOLD

0.68

Volume Ratio

Feb 18, 2026

Next Earnings

14

+ve Days (30d)

14

-ve Days (30d)

MNOV Stock Summary

Last updated Jan 30, 2026

MNOV is currently trading at $1.72, positioned above its 200-day moving average of $1.38, indicating a long-term uptrend. The stock has a 52-week range of $1.13 to $2.06.

Technical Analysis: The 50-day moving average stands at $1.5, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 60.563, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.01, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates MNOV at 58.5/100 with a HOLD recommendation.

MNOV (Medicinova, Inc.) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 60.563
CMF (20) 0.01
ROC (10) 8.861
ADX (14) 29.689
Indicator Value
MACD (12,26,9) 0.099
AROONOSC (14) 71.429
WILLAMS %R (14) -40.206
MFI (14) 74.233
MNOV Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

MNOV Price vs Max Options Open Interest
MNOV Max Change In Options Open Interest

MNOV Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MNOV Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MNOV Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

MNOV Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Medicinova, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.

MNOV Moving Averages Analysis

Medicinova, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

Medicinova, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026

MNOV (Medicinova, Inc.) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 1.75
20 1.59
30 1.51
50 1.5
100 1.4
200 1.38

MNOV Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 84.5 million
Earnings/Share ($) -0.25
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.38
EPS Estimate Next Year ($) -0.32
WallStreet Target Price ($) 10
Most Recent Quarter